1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow parthenolide: new trials by email Literature Review of parthenolide trials Research Report on parthenolide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biomarker-based Trial of NPC-1 for Alzheimer's Pathology natural product combination-1 (NPC1) - Alzheimer Disease, Mild Cognitive Impairment (MCI) | Phase 2 | Recruiting | Massachusetts General Hospital | 40 | 2026-04-01 | 2026-10-13 |
| Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate Goldnatriomthiosulphate, MDBGN, parthenolide - Allergic Contact Dermatitis | Phase 2 | Completed | Mekos Laboratories AS | 60 | 2005-04-01 | 2006-02-27 |
Alzheimer Disease (1) · Cognitive Dysfunction (1) · Dermatitis, Allergic Contact (1)
Massachusetts General Hospital (1) · Mekos Laboratories AS (1)
Denmark (1) · United States (1)
Gene Bowman, ND, MPH (1) · Klaus E Andersen, Prof. (1)